Drug Trial Radar · NCT02679144
Neuroblastoma Maintenance Therapy Trial
Last checked: Nov 20, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
441
Planned (sponsor's estimate)
Start
Feb 2016
Primary completion
Feb 2028
Study completion Feb 2033
Sponsor
- Lead sponsor
- Giselle ShollerAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Beat NB Cancer Foundation; Team Parker for Life
- First posted
- Feb 10, 2016
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 1 year, up to 30 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Difluoromethylornithine (DFMO) will be used in an open label, single agent, multicenter, study for patients with neuroblastoma in remission. In this study subjects will receive 730 Days of oral difluoromethylornithine (DFMO) at a dose of 750 mg/m2 ± 250 mg/m2 BID (strata 1, 2, 3, and 4) OR 2500 mg/m2 BID (stratum 1B) on each day of study. This study will focus on the use of DFMO in high risk neuroblastoma patients that are in remission as a strategy to prevent recurrence.
Conditions
- Neuroblastoma
Interventions
Difluoromethylornithine (DFMO)Drug
Subjects will receive 730 Days of oral difluoromethylornithine (DFMO) at a dose of 750 mg/m2 ± 250 mg/m2 BID (strata 1, 2, 3, and 4) OR 2500 mg/m2 BID (stratum 1B) on each day of study.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with event free survival (EFS) during study.Time frame: 2 years
Locations
46 sites in 2 countries. Site status is shown where the registry gives one.
University of Alabama, Children's of Alabama
Birmingham, Alabama
Arkansas Children's Hospital
Little Rock, Arkansas
UCSF Benioff Children's Hospital Oakland-
Oakland, California
Rady Children's Hospital
San Diego, California
Rocky Mountain Pediatric Hematology
Denver, Colorado
Connecticut Children's Hospital
Hartford, Connecticut
University of Florida
Gainesville, Florida
Arnold Palmer Hospital for Children
Orlando, Florida
All Children's Hospital Johns Hopkins Medicine
St. Petersburg, Florida
St. Joseph's Children's Hospital
Tampa, Florida
Augusta University Health
Augusta, Georgia
St. Lukes
Boise, Idaho
Advocate Aurora Research Institute
Chicago, Illinois
University of Iowa
Iowa City, Iowa
Kentucky Children's Hospital
Lexington, Kentucky
Norton Children's Research Institute/Affiliated with University of Louisville School of Medicine
Louisville, Kentucky
Tufts Medical Center
Boston, Massachusetts
Helen DeVos Children's Hospital
Grand Rapids, Michigan
Children's Hospital and Clinics of Minnesota
Minneapolis, Minnesota
Children's Mercy Hospitals and Clinics
Kansas City, Missouri
Cardinal Glennon Children's Medical Center
St Louis, Missouri
Hackensack University Medical Center
Hackensack, New Jersey
NYU Langone Health Hassenfeld Children's Hospital
New York, New York
The Children's Hospital at Montefiore
The Bronx, New York
Levine Children's Hospital
Charlotte, North Carolina
Duke University
Durham, North Carolina
Cleveland Clinic Children's
Cleveland, Ohio
Nationwide Children's Hospital
Columbus, Ohio
Randall Children's Hospital
Portland, Oregon
Penn State Milton S. Hershey Medical Center and Children's Hospital
Hershey, Pennsylvania
Hasbro Children's Hospital
Providence, Rhode Island
Medical University of South Carolina
Charleston, South Carolina
Monroe Carrell Jr. Children's Hospital at Vanderbilt
Nashville, Tennessee
Dell Children's Blood and Cancer Center
Austin, Texas
Children's Medical Center
Dallas, Texas
Texas Children's Cancer and Hematology Centers
Houston, Texas
Primary Children's Hospital
Salt Lake City, Utah
Children's Hospital of The King's Daughters
Norfolk, Virginia
Virginia Commonwealth University
Richmond, Virginia
Medical College of Wisconsin
Milwaukee, Wisconsin
Showing 40 of 46 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.